Haemonetics (STU:HAZ) Net Interest Margin (Bank Only) %


STU:HAZ Haemonetics Corp STU:HAZ
79 GF Score
Price €65.00
GF Value €73.57
! 4 Warning Signs
View Full Analysis

What is Haemonetics Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

STU:HAZ
79GF Score
Haemonetics Corp STU:HAZ
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Haemonetics (STU:HAZ) Overvalued in 2026?

Based on GuruFocus' analysis, Haemonetics stock appears to be undervalued. The current stock price of €65.00 is trading 11.6% below its estimated GF Value™ of €73.57.

Key valuation signals for STU:HAZ:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €73.57 vs. price of €65.00 (11.6% below fair value)
  • GF Score™: 79/100 with 4 warning signs

No single metric tells the full story. See the STU:HAZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Haemonetics Business Description

Other Exchanges HAE:USA
Address 125 Summer Street, Boston, MA, USA, 02110
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.
79GF Score

Get the complete analysis for STU:HAZ

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€65.00
Price
€73.57
GF Value